Johnson, Richard J. http://orcid.org/0000-0003-3312-8193
Perez-Pozo, Santos E.
Lillo, Julian Lopez
Grases, Felix
Schold, Jesse D.
Kuwabara, Masanari
Sato, Yuka
Hernando, Ana Andres
Garcia, Gabriela
Jensen, Thomas
Rivard, Christopher
Sanchez-Lozada, Laura G.
Roncal, Carlos
Lanaspa, Miguel A.
Funding for this research was provided by:
Universitat de les Illes Balears (None)
Article History
Received: 29 December 2017
Accepted: 18 October 2018
First Online: 8 November 2018
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of the Illes Balears Community (CEIC-IB; resolution: IP IB-850/07) and was registered on ExternalRef removed [NCT00639756]. All subjects provided written consent to participate.
: Yes
: Dr. Johnson, Lanaspa and Sanchez-Lozada are members of Colorado Research Partners LLC that is making inhibitors of fructose metabolism. Dr. Johnson is also on the Scientific Board of Kibow, Inc. and XORT therapeutics. Dr. Johnson has also received honoraria from Danone and Astra.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.